On This Page (5 sections)
Alteplase 100 mg IV infusion over 2h (or 50 mg IV push in cardiac arrest)
Enoxaparin 1 mg/kg SubQ q12h OR Heparin 80 U/kg bolus + 18 U/kg/h infusion
Avoid fluid loading (< 500 mL crystalloid); Norepinephrine first-line vasopressor
All 8 criteria negative + low pretest probability rules out PE without D-dimer
Age x 10 mcg/L for patients > 50 years old (increases specificity by 20%)
Clinical decision rules for pre-test probability of PE; if low risk, apply PERC rule to rule out without D-dimer.
Hemodynamically stable (SBP >= 90) but with evidence of RV strain (elevated troponin, BNP, RV/LV ratio > 0.9 on CT, McConnell sign on echo); monitor in ICU/step-down and consider catheter-directed thrombolysis.
Bottom-Line Clinical Pearl
Acute pulmonary embolism kills via acute right ventricular failure and obstructive shock, NOT hypoxemia. Risk stratify immediately: Massive PE (sustained SBP < 90 mmHg or vasopressor requirement) mandates immediate systemic thrombolysis (Alteplase 100 mg IV over 2h or 50 mg bolus in cardiac arrest). In submassive PE (normotensive with RV strain on POCUS or elevated troponin/BNP), start therapeutic parenteral anticoagulation immediately and monitor closely in an ICU/stepdown setting. Never fluid-overload an acutely failing right ventricle.
The pathophysiology of fatal pulmonary embolism is acute right ventricular (RV) afterload mismatch. As pulmonary vascular resistance spikes, the thin-walled RV dilates, shifts the interventricular septum into the left ventricle (reducing LV preload and stroke volume), and causes fatal circulatory collapse. Classify the clinical severity immediately upon arrival:
| Severity Category | Clinical & Hemodynamic Criteria | Myocardial Biomarkers | Immediate Emergency Action |
|---|---|---|---|
| Massive PE (High-Risk) | Sustained SBP < 90 mmHg for > 15 min, or drop >= 40 mmHg, or vasopressor requirement; cardiac arrest | Elevated Troponin/BNP common | Immediate Systemic Thrombolysis (Alteplase) or surgical embolectomy; Norepinephrine infusion; avoid intubation if possible. |
| Submassive PE (Intermediate-High) | Normotensive (SBP >= 90 mmHg) + BOTH RV dysfunction (POCUS/CT) AND positive biomarkers (Troponin/BNP) | Elevated Troponin I/T and/or BNP | Therapeutic Anticoagulation immediately; admit to ICU/stepdown; PERT team consultation for catheter-directed thrombolysis. |
| Submassive PE (Intermediate-Low) | Normotensive (SBP >= 90 mmHg) + EITHER RV dysfunction OR positive biomarker (not both) | Either Troponin OR BNP elevated | Therapeutic Anticoagulation; telemetry monitoring; assess sPESI score. |
| Low-Risk PE | Normotensive; no RV strain on imaging; normal cardiac biomarkers; sPESI = 0 | Normal Troponin and BNP | Therapeutic Anticoagulation (DOAC: Apixaban/Rivaroxaban); potential for same-day discharge or observation unit. |
Critical Pitfall / Contraindication
The Right Ventricular Fluid Overload Trap: In obstructive shock from acute PE, the instinct to administer large fluid boluses is deadly. The RV is already at the steep, non-compliant end of the Frank-Starling curve. Excess crystalloid volume worsens RV wall tension, compresses the left ventricle, and precipitates cardiac arrest. Limit crystalloid resuscitation to a single 250–500 mL bolus. If MAP is < 65 mmHg, start Norepinephrine immediately to restore coronary perfusion to the failing RV.
Never order a D-dimer or CT angiogram without first establishing clinical pretest probability. Over-testing leads to false positives, contrast-induced reactions, and unnecessary radiation exposure.
| PERC Rule (Pulmonary Embolism Rule-out Criteria) | Clinical Threshold | Application Rule |
|---|---|---|
| 1. Age < 50 years | Age 50 or older fails PERC | Applicable ONLY if clinical pretest probability is LOW (< 15%). |
| 2. Heart rate < 100 bpm | Pulse >= 100 bpm fails PERC | If ALL 8 criteria are negative, PE is ruled out (< 1.8% risk). |
| 3. Room air SpO2 >= 95% | SpO2 <= 94% fails PERC | NO D-dimer and NO imaging is indicated. |
| 4. No prior DVT or PE history | Any prior VTE fails PERC | If any single criterion is positive, proceed to D-dimer testing. |
| 5. No recent trauma or surgery (< 4 weeks) | General anesthesia/trauma fails | PERC sensitivity > 97%. |
| 6. No hemoptysis | Coughing blood fails PERC | Prevents unnecessary diagnostic imaging in emergency departments. |
| 7. No exogenous estrogen use | OCPs, HRT, SERMs fail PERC | Estrogen increases procoagulant synthesis. |
| 8. No unilateral leg swelling | Asymmetric calf edema fails PERC | Assesses for concurrent deep venous thrombosis. |
| Wells Criteria for Pulmonary Embolism | Points | Two-Tier Interpretation & Pathway |
|---|---|---|
| Clinical signs/symptoms of DVT (leg swelling, pain with palpation) | 3.0 | Score <= 4.0: PE Unlikely -> Check D-dimer (use age-adjusted cutoff). |
| PE is #1 diagnosis OR equally likely as other differential | 3.0 | If D-dimer normal -> PE ruled out (no imaging). |
| Heart rate > 100 bpm | 1.5 | If D-dimer elevated -> CT Pulmonary Angiography (CTPA). |
| Immobilization >= 3 consecutive days OR surgery in past 4 weeks | 1.5 | Score > 4.0: PE Likely -> Proceed directly to CT Pulmonary Angiogram. |
| Previous objectively diagnosed DVT or PE | 1.5 | Do NOT order D-dimer in 'PE Likely' group (high false negative rate). |
| Hemoptysis | 1.0 | Pregnancy/Renal failure: Use V/Q scan or bilateral lower extremity ultrasound. |
| Malignancy (active treatment within 6 months or palliative) | 1.0 | Age-Adjusted D-Dimer formula: Age x 10 mcg/L for patients > 50 years. |
In an unstable patient too ill to travel to the CT scanner, bedside point-of-care ultrasound (POCUS) provides immediate diagnostic confirmation of right ventricular strain and cor pulmonale.
| POCUS Sign | Ultrasound View | Pathologic Mechanism | Diagnostic Utility |
|---|---|---|---|
| McConnell's Sign | Apical 4-chamber view | Severe hypokinesis or akinesis of the RV free wall with normal or hyperdynamic RV apical contractility. | Highly specific (94–96%) for acute pulmonary embolism. |
| RV/LV Ratio > 1.0 | Apical 4-chamber/Subxiphoid | End-diastolic RV diameter exceeds LV diameter (normally RV is 2/3 size of LV). | Hallmark of right ventricular enlargement and hemodynamic strain. |
| Interventricular Septal Flattening ('D-Sign') | Parasternal short-axis view | High RV pressure flattens the septum toward the left ventricle during both systole and diastole. | Indicates severe RV pressure and volume overload. |
| Plethoric, Non-Collapsible IVC | Subxiphoid longitudinal | Dilated inferior vena cava (> 2.1 cm) with < 50% collapsibility during inspiration. | Reflects elevated central venous pressure (RAP > 15 mmHg). |
| 60/60 Sign | Parasternal short-axis (pulmonic valve) | Pulmonary acceleration time < 60 ms with midsystolic notch, plus tricuspid peak gradient < 60 mmHg. | Differentiates acute PE from chronic pulmonary arterial hypertension. |
| Clinical Indication | Drug & Regimen | Route & Timing | Clinical Pearls & Safety Protocols |
|---|---|---|---|
| Massive PE (Systemic Thrombolysis) | Alteplase (tPA) 100 mg | IV infusion over 2 hours | Reconstitute 100 mg in sterile water; infuse via dedicated line. Hold heparin during infusion. |
| Cardiac Arrest from Suspected PE | Alteplase (tPA) 50 mg bolus | IV push over 2 minutes (may repeat in 15 min) | Perform CPR for at least 30–60 minutes post-bolus to allow clot dissolution and pulmonary reperfusion. |
| Anticoagulation (Parenteral: Preferred) | Enoxaparin (LMWH) 1 mg/kg | SubQ q12h (or 1.5 mg/kg once daily) | Preferred in stable submassive PE; lower major bleeding and HIT rates than unfractionated heparin. |
| Anticoagulation (Renal Impairment/Unstable) | Unfractionated Heparin (UFH) 80 U/kg bolus, 18 U/kg/h | IV infusion titrated to aPTT 60–80 sec (or anti-Xa 0.3–0.7) | Mandatory if CrCl < 30 mL/min, severe obesity, or patient may require emergent catheterization/thrombolysis. |
| Anticoagulation (Oral: Low Risk PE) | Apixaban 10 mg BID x 7 days, then 5 mg BID OR Rivaroxaban 15 mg BID x 21 days, then 20 mg daily | PO with meals (for rivaroxaban) | Direct oral anticoagulants (DOACs) do not require heparin lead-in. Preferred for outpatient management. |
Endotracheal intubation in massive pulmonary embolism is a high-risk procedure with catastrophic mortality rates (> 30% peri-intubation arrest). Positive pressure ventilation increases intrathoracic pressure, dramatically reduces venous return to the right heart, and further spikes pulmonary vascular resistance, collapsing the RV.
- Delay Intubation if Possible: Use high-flow nasal cannula (HFNC) or non-rebreather mask to maintain oxygenation while thrombolytic therapy or anticoagulation takes effect.
- Pre-Emptive Hemodynamic Resuscitation: Start a Norepinephrine infusion (0.05–0.5 mcg/kg/min) prior to induction to maintain systemic vascular resistance and coronary perfusion pressure.
- Hemodynamically Neutral Induction: Use Ketamine (1.0–1.5 mg/kg IV) or Etomidate (0.2–0.3 mg/kg IV). AVOID propofol (causes profound vasodilation and myocardial depression).
- Ventilator Strategy Post-Intubation: Use lung-protective low tidal volumes (6 mL/kg IBW), low PEEP (<= 5 cmH2O to minimize pulmonary vascular resistance), and maintain driving pressure < 15 cmH2O. Avoid hypercapnia and acidosis (potent pulmonary vasoconstrictors).
Test Your Acute Pulmonary Embolism & Right Heart Strain Clinical Acumen
Directly launch an active-recall practice block from our validated question bank with comprehensive explanations and distractor analyses.
Distinguish primary life-threats from mimics. On board exams (COMLEX Level 1, 2-CE, 3 & USMLE), initial stabilizing interventions (airway, IV access, non-invasive ventilation, empiric reversal) always take precedence over diagnostic imaging.
Evaluate autonomic tone: Sympathetic viscerosomatics (T1–L2) cause acute paraspinal tissue texture changes (erythema, bogginess, hypertonicity). Suboccipital release (CN X Vagus) and rib raising normalize autonomic outflow and thoracic cage mechanics.